ClinicalTrials.govpublic full text
Neoadjuvant INBRX-106 in Combination With Pembrolizumab for Stage II/III TNBC Patients
triple negative breast cancer
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 130989
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.